Januvia Clinical Trials Januvia RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Combination of Ertugliflozin And Sitagliptin Efficacy, Safety & Tolerability (CEASE Diabetes) Study
Conditions:   Efficacy;   Safety;   Tolerability Intervention:   Drug: Combinations of Oral Blood Glucose Lowering Drugs Sponsors:   Getz Pharma;   PCDA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2022 Category: Research Source Type: clinical trials

Comparative Bioavailability Study of Sitagliptin/Metformin 50 mg/1000 mg Tablets in Healthy Male and Female Volunteers
Conditions:   Bioequivalence;   Type 2 Diabetes Intervention:   Drug: Sitagliptin/metformin hydrochloride (HCl) 50/1000 mg film-coated tablet Sponsor:   Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2022 Category: Research Source Type: clinical trials

Comparative Bioavailability Study of Metformin/Sitagliptin 850 mg/50 mg Tablets in Healthy Male and Female Volunteers
Conditions:   Bioequivalence;   Diabetes Mellitus, Type 2 Intervention:   Drug: Sitagliptin/Metformin HCl 50/850 mg film-coated tablet Sponsor:   Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2022 Category: Research Source Type: clinical trials

Comparative Bioavailability Study of Sitagliptin/Metformin 50 mg/1000 mg Tablets in Healthy Male and Female Volunteers
Conditions:   Bioequivalence;   Type 2 Diabetes Intervention:   Drug: Sitagliptin/metformin hydrochloride (HCl) 50/1000 mg film-coated tablet Sponsor:   Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2022 Category: Research Source Type: clinical trials

Comparative Bioavailability Study of Metformin/Sitagliptin 850 mg/50 mg Tablets in Healthy Male and Female Volunteers
Conditions:   Bioequivalence;   Diabetes Mellitus, Type 2 Intervention:   Drug: Sitagliptin/Metformin HCl 50/850 mg film-coated tablet Sponsor:   Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2022 Category: Research Source Type: clinical trials

Comparative Bioavailability Study of Sitagliptin/Metformin 50 mg/1000 mg Tablets in Healthy Male and Female Volunteers
Conditions:   Bioequivalence;   Type 2 Diabetes Intervention:   Drug: Sitagliptin/metformin hydrochloride (HCl) 50/1000 mg film-coated tablet Sponsor:   Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2022 Category: Research Source Type: clinical trials

Comparative Bioavailability Study of Metformin/Sitagliptin 850 mg/50 mg Tablets in Healthy Male and Female Volunteers
Conditions:   Bioequivalence;   Diabetes Mellitus, Type 2 Intervention:   Drug: Sitagliptin/Metformin HCl 50/850 mg film-coated tablet Sponsor:   Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2022 Category: Research Source Type: clinical trials

Comparative Bioavailability Study of Sitagliptin/Metformin 50 mg/1000 mg Tablets in Healthy Male and Female Volunteers
Conditions:   Bioequivalence;   Type 2 Diabetes Intervention:   Drug: Sitagliptin/metformin hydrochloride (HCl) 50/1000 mg film-coated tablet Sponsor:   Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2022 Category: Research Source Type: clinical trials

Comparative Bioavailability Study of Metformin/Sitagliptin 850 mg/50 mg Tablets in Healthy Male and Female Volunteers
Conditions:   Bioequivalence;   Diabetes Mellitus, Type 2 Intervention:   Drug: Sitagliptin/Metformin HCl 50/850 mg film-coated tablet Sponsor:   Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2022 Category: Research Source Type: clinical trials

Comparative Bioavailability Study of Sitagliptin/Metformin 50 mg/1000 mg Tablets in Healthy Male and Female Volunteers
Conditions:   Bioequivalence;   Type 2 Diabetes Intervention:   Drug: Sitagliptin/metformin hydrochloride (HCl) 50/1000 mg film-coated tablet Sponsor:   Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2022 Category: Research Source Type: clinical trials

Comparative Bioavailability Study of Metformin/Sitagliptin 850 mg/50 mg Tablets in Healthy Male and Female Volunteers
Conditions:   Bioequivalence;   Diabetes Mellitus, Type 2 Intervention:   Drug: Sitagliptin/Metformin HCl 50/850 mg film-coated tablet Sponsor:   Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2022 Category: Research Source Type: clinical trials

Comparative Bioavailability Study of Sitagliptin/Metformin 50 mg/1000 mg Tablets in Healthy Male and Female Volunteers
Conditions:   Bioequivalence;   Type 2 Diabetes Intervention:   Drug: Sitagliptin/metformin hydrochloride (HCl) 50/1000 mg film-coated tablet Sponsor:   Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2022 Category: Research Source Type: clinical trials

Comparative Bioavailability Study of Metformin/Sitagliptin 850 mg/50 mg Tablets in Healthy Male and Female Volunteers
Conditions:   Bioequivalence;   Diabetes Mellitus, Type 2 Intervention:   Drug: Sitagliptin/Metformin HCl 50/850 mg film-coated tablet Sponsor:   Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2022 Category: Research Source Type: clinical trials

Comparative Bioavailability Study of Sitagliptin/Metformin 50 mg/1000 mg Tablets in Healthy Male and Female Volunteers
Conditions:   Bioequivalence;   Type 2 Diabetes Intervention:   Drug: Sitagliptin/metformin hydrochloride (HCl) 50/1000 mg film-coated tablet Sponsor:   Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2022 Category: Research Source Type: clinical trials